...
首页> 外文期刊>Research Journal of Phytochemistry >> Hypolipidemic and Hypocholesterolemic Effect of Elephantopus scaber in Streptozotocin Diabetic Rats
【24h】

> Hypolipidemic and Hypocholesterolemic Effect of Elephantopus scaber in Streptozotocin Diabetic Rats

机译:<浓度> eLephantopus scaber在链脲佐菌素糖尿病大鼠中的低血散和脱胆固醇效果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

diabetic rats . Elephantopus scaber methanol, hexane and acetone extracts (150 mg kg -1 b.wt.) were administered orally for 60 days to streptozotocin (STZ) (60 mg kg -1 b.wt.) induced male diabetic > wistar rats . Humulin and glibenclamide were also administered for 60 days to streptozotocin (STZ) (60 mg kg -1 b.wt.) induced male diabetic > wistar rats . On the 61st day, the animals were sacrificed and the blood collected was tested for cholesterol, LDL, HDL and VLDL, respectively. Results: Data was analyzed using analysis of variance and student's t-test and a level of p<0.05 was considered statistically significant. Administration of the different extracts of E. scaber brought about a significant reduction in serum cholesterol, LDL, VLDL and triglycerides and increase in the HDL-cholesterol in > diabetic rats . Conclusion: Hence, this study proves the protective and restorative effect of E. scaber in reverting the lipid alterations and complications of diabetes. Due to such attributes, E. scaber can be a source of potent drug to mitigate the complications of diabetes.]]>
机译:<![cdata [背景和目标: elephantopus scaber (菊属植物)广泛用于传统的药物系统,以治疗糖尿病及其在印度的并发症。该草药的部件传统上用于治疗许多国家的许多疾病。据报道,该植物具有多种生物学性质。本研究旨在探讨据据报道的抗糖尿病活性的抗胆固醇血液潜力。 方法:第本研究探讨了所选植物根部对STZ诱导的血清脂质对血清脂质的影响>糖尿病大鼠。 Elephantopus scaber 甲醇,己烷和丙酮萃取物(150mg kg -1-1b.wt.)口服对链脲佐菌素(stz)进行60天(60 mg kg -1 b.wt.)诱导的男性糖尿病> wistar大鼠。 Sumulin和Glibenclamide也施用60天至链脲佐菌素(STZ)(60mg kg -1 -1 / sop> b.wt.)诱导的雄性糖尿病> wistar大鼠。在第61天,处死动物,分别对收集的血液进行胆固醇,LDL,HDL和VLDL。 结果:使用方差分析和学生的T检验分析数据,P <0.05的水平被认为是统计学意义。施用不同提取物的 E.Scaber 在血清胆固醇,LDL,VLDL和甘油三酯中产生显着降低,并在<强>糖尿病大鼠中增加了HDL-胆固醇。 结论:因此,本研究证明了 emaber 在恢复脂质改变和糖尿病并发症中的保护和修复效果。由于这种属性, E. caber 可以是减轻糖尿病并发症的有效药物的来源。]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号